Israeli drug prevents 100% of COVID patients from deteriorating in trial

mellowyellow

mellowyellow

Well-known Member
All 18 Covid-19 patients hospitalized with moderate or severe symptoms who were administered the drug Amor-18 developed by Israeli biotech company Amorphical in a phase II clinical trial recovered and were discharged in a few days, the company announced Wednesday. Of the 19 individuals who were given a placebo, six had to be transferred to intensive care, and two died.

https://www.jpost.com/health-and-wellness/coronavirus/article-689543
 

Alice November said:
Not for the placebo recipients who died it doesn't.
Click to expand...
That was my thought too, but apparently the researchers felt the same way because the article also says this:

"As part of compassionate care, two other patients in a very serious condition were given the drug. Both recovered and were discharged."

What sounds super exciting, unless I am mis-reading the article, is that this sounds like a treatment that works for even the common cold!
 
You must log in or register to reply here.

Back
Top